FDA Import Refusal 1FX-3997052-1/80002/1 — CAPLIN POINT

CAPLIN POINT — FEI 3023419653

The FDA refused shipment 1FX-3997052-1/80002/1 from CAPLIN POINT (Guatemala) on September 15, 2026. The refused product falls under Drugs and Biologics — IBUPROFEN (ANTI-INFLAMMATORY). Cited charge: 75 This firm has 5 or more other import refusals on record.

Refusal Details

Date
September 15, 2026
Country
Guatemala
Product Category
Drugs and Biologics
Product Code
62GCY41 IBUPROFEN (ANTI-INFLAMMATORY)
Charges
75